News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
OKYO Pharma Announces U.S. IND Filing on OK-101 for the Treatment of Dry Eye Disease
Tuesday, November 22, 2022OKYO Pharma Limited an ophthalmologyfocused biopharmaceutical company which is developing OK to treat dry eye disease to address the significant unmet need in this multibilliondollar market today announced that it filed an Investigational New Drug IN...
Healiva® Acquires Critical Cell Therapy Manufacturing Assets From B. Braun
Tuesday, November 22, 2022Healiva a patientcentric company delivering lifeenhancing precision medicine for patients with chronic and acute wounds announced today the acquisition of critical manufacturing assets from B Braun Medical AG Switzerland an affiliate of German medica...
Upstaza™ Gene Therapy Granted Marketing Authorization for AADC deficiency by UK's MHRA
Friday, November 18, 2022PTC Therapeutics Inc announced that Upstaza was granted authorization by the Medicines and Healthcare Products Regulatory Agency MHRA in Great Britain
TJP Labs Inc. Amends Its Drug Establishment License and Achieves Approval for Active Pharmaceutical Ingredients
Friday, November 18, 2022TJP Labs Inc is North Americas leading fullservice contract manufacturer of premier nextgeneration products focusing on modern oral nicotine pouches and oral delivery solutions for caffeine and other nutraceutical products Today TJP Labs announced th...
Mindset Pharma and PharmAla Enter into Exclusive Sales Agreement for the Sale and Distribution of Pharmaceutical Grade Psilocybin
Thursday, November 17, 2022Mindset Pharma Inc a drug discovery company developing novel optimized nextgeneration psychedelic and nonpsychedelic medications to treat neuropsychiatric and neurological disorders with unmet medical needs and PharmAla Biotech Holdings Inc a biotech...
Skye Bioscience Initiates First-in-Human Phase 1 Clinical Trial for SBI-100
Thursday, November 17, 2022Skye Bioscience Inc a pharmaceutical company developing a proprietary synthetic cannabinoid derivative to treat glaucoma has initiated screening for its firstinhuman Phase trial of SBI Ophthalmic Emulsion SBI OE As previously announced this study ha...
Chain Pharmaceuticals GmbH Announces Its Phytocannabinoid Drug Discovery Platform
Wednesday, November 16, 2022Dr Pierre Debs PhD announced today the launch of Chain Pharmaceuticals GmbH a phytocannabinoid drug discovery company leveraging machine learning and real world
ZYUS Announces Database Lock for its Phase 1 First-in-Human Clinical Trial
Wednesday, November 16, 2022ZYUS Life Sciences Inc a Canadianbased life sciences company leading scientific research and global development of innovative cannabinoidbased pharmaceutical drug products today announced the successful completion of database lock for its Phase clin...
Ono Pharmaceutical and Captor Therapeutics Announce Drug Discovery Collaboration to Develop Small Molecule Protein Degraders for the Treatment of Neurodegenerative Diseases
Tuesday, November 15, 2022Captor Therapeutics SA a leader in the development of Targeted Protein Degradation TPDbased drugs today announces a worldwide drug discovery collaboration with Ono Pharmaceutical Co Ltd
Indivior To Acquire Opiant Pharmaceuticals
Tuesday, November 15, 2022Indivior PLC and Opiant Pharmaceuticals Inc announced that the companies have entered into a definitive agreement under which Indivior will acquire Opiant for an upfront consideration of per share in cash approximately million in aggregate plus up...
